Opendata, web and dolomites

NoBiasFluors SIGNED

Non-biased fluorescent dyes as markers of drugs for optical in cellulo and in vivo imaging

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 NoBiasFluors project word cloud

Explore the words cloud of the NoBiasFluors project. It provides you a very rough idea of what is the project "NoBiasFluors" about.

vivo    atom    of    radioactive    ideally    labeling    positive    monitoring    markers    careful    solution    structure    assays    nobiasfluors    pi    alzheimer    cell    drugs    infrared    majority    applicability    academic    easily    mechanism    drug    pet    representative    charge    interdisciplinary    intrinsic    transfer    safety    18f    suffers    binders    radioactivity    small    breakthrough    humans    prodrugs    compatible    mice    lectins    limits    nucleopeptides    despite    near    critical    usually    positron    anticancer    conjugation    advantage    cellulo    dye    extended    intersectoral    data    optimization    delivers    action    sized    labeled    optical    accurate    dyes    fluorescent    detectable    alkylaminoferrocene    biased    teams    replace    tomography    imaging    molecular    medium    emission    clinical    marker    moieties    single    confirm    peptides    consisting    elaborated    confirmation    biomolecules    industrial    disease    polarity    discovery    negative    harmful    red    weight    environment    operative   

Project "NoBiasFluors" data sheet

The following table provides information about the project.

Coordinator
FRIEDRICH-ALEXANDER-UNIVERSITAET ERLANGEN NUERNBERG 

Organization address
address: SCHLOSSPLATZ 4
city: ERLANGEN
postcode: 91054
website: www.uni-erlangen.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 699˙200 €
 EC max contribution 671˙600 € (96%)
 Programme 1. H2020-EU.1.3.3. (Stimulating innovation by means of cross-fertilisation of knowledge)
 Code Call H2020-MSCA-RISE-2019
 Funding Scheme MSCA-RISE
 Starting year 2020
 Duration (year-month-day) from 2020-01-01   to  2023-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    FRIEDRICH-ALEXANDER-UNIVERSITAET ERLANGEN NUERNBERG DE (ERLANGEN) coordinator 133˙400.00
2    LIMITED LIABILITY SCIENTIFIC SERVICE COMPANY OTAVA UA (KYIV) participant 230˙000.00
3    INSTITUTUL DE CHIMIE MACROMOLECULARA PETRU PONI RO (IASI) participant 142˙600.00
4    CONSIGLIO NAZIONALE DELLE RICERCHE IT (ROMA) participant 92˙000.00
5    NAUKOVO VYROBNICHYJ KOOPERATYV LECTINOTEST UA (LVIV) participant 73˙600.00
6    THE REGENTS OF THE UNIVERSITY OF CALIFORNIA US (OAKLAND CA) partner 0.00

Map

 Project objective

Imaging of distribution of drugs in mice delivers accurate information for confirmation that the mechanism of action elaborated in cell-based assays is also operative in vivo. These data are critical for the transfer of drug discovery process from pre-clinical to clinical phase. To enable the imaging, drugs should be labeled with easily detectable moieties, e.g. radioactive markers and fluorescent dyes. Ideally, the markers should not affect in vivo properties of the drugs that can be better achieved with radioactive markers, since they can be selected to be small: e.g. a single atom marker 18F applied in positron emission tomography. Despite this intrinsic advantage, PET suffers from safety issues, since radioactivity is harmful to humans and environment. In terms of safety optical imaging is much better and, therefore, in future can replace PET. However, fluorescent dyes compatible with the optical imaging are usually extended pi-systems carrying overall positive or negative charge. Their conjugation strongly affects properties of the majority of medium sized and low molecular weight drugs that limits the applicability of this method in drug discovery. The interdisciplinary and intersectoral consortium NoBiasFluors consisting of 4 academic and 2 industrial teams aims at achieving a breakthrough solution of this problem. We will develop non-biased red and near infrared fluorescent dyes, which are compatible with in vivo optical imaging and do not affect properties of drugs upon their conjugation. This goal will be achieved by the careful optimization of dye structure, polarity and charge. We will confirm the functionality of the developed dyes for labeling of representative drugs (anticancer N-alkylaminoferrocene-based prodrugs, D-peptides targeting Alzheimer’s disease) and binders of biomolecules (nucleopeptides and lectins) and monitoring their distribution both in cellulo and in vivo (for a selected labeled drug).

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NOBIASFLUORS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NOBIASFLUORS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.3.)

CONMECH (2019)

Nonsmooth Contact Dynamics

Read More  

VIDEC (2020)

Visualizing Death Inducing Protein Complexes

Read More  

CoSP (2019)

Combinatorial Structures and Processes

Read More